a trial was carried out in clinical cases of skin disease which were randomly allocated to twice daily treatment with either amoxycillin alone ( 10 or 20 mg/kg ) , or with clavulanate-potentiated amoxycillin ( 12.5 or 25 mg/kg of a 1:4 ratio ) .
C0002645
amoxycillin
C0054066
clavulanate-potentiated